“deals” Archives

in
Entry Author Date Location
MagniX, Eviation Partner to Develop Electric Plane For Short Flights 04/22/19 Seattle
TerraClear Raises $4.7M for Machine Designed to Pick Rocks from Soil 04/19/19 Seattle
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise 04/18/19 Seattle
Hookipa’s IPO Raises $84M for Drugs to Reprogram the Immune System 04/18/19 New York
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
Seattle’s Outreach Joins Unicorn Ranks With $114M Funding Round 04/16/19 Seattle
6sense Raises $27M to Uncover Hidden Interests of B2B Buyers 04/16/19 San Francisco
Founders’ Co-op Raises $25M to Back More Pacific Northwest Startups 04/16/19 Seattle
Show Me The Money: Seattle’s Showdigs Gets $3M for Real Estate Tools 04/15/19 Seattle
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon 04/15/19 New York
Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs 04/12/19 San Francisco
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Boston Tech Watch: Tufin, Facebook, RightHand, Diameter & Jebbit 04/12/19 Boston
WI Watchlist: DotCom Therapy, Nordic, UWM, Epic 04/11/19 Wisconsin
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials 04/11/19 Raleigh Durham
Apana Gulps Down $11M to Help Costco, Other Clients Track Water Use 04/09/19 Seattle
Sobriety Pays: DynamiCare Gamifies Staying Clean for Recovering Addicts 04/09/19 Boston
VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less 04/09/19 National
RiskLens Raises $20M for Software That Quantifies Cyber Risk 04/08/19 Seattle
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases 04/08/19 Boston
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing 04/03/19 San Francisco
Dyne Therapeutics Emerges With $50M to Take On Rare Muscle Disease 04/03/19 Boston
Lear to Acquire Seattle Connected Vehicle Tech Firm Xevo For $320M 04/02/19 Seattle
Seattle Venture Capital Watch: Crelate, Cyemptive, Blue Canoe & More 04/02/19 Seattle
EzCater Celebrates “Unicorn” Status After $150M Funding Round 04/02/19 Boston
SpringWorks, Armed with Ex-Pfizer Cancer Drugs, Reloads with $125M 04/01/19 New York
Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre 04/01/19 Boston
Page 1 of 287 next page »